Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 38,350 KRW
Change Today 0.00 / 0.00%
Volume 220.1K
063160 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:27 AM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

ckd bio corp (063160) Snapshot

Open
38,700
Previous Close
38,350
Day High
39,350
Day Low
37,300
52 Week High
07/2/15 - 39,350
52 Week Low
07/2/14 - 13,500
Market Cap
200.6B
Average Volume 10 Days
320.1K
EPS TTM
-85.00
Shares Outstanding
5.2M
EX-Date
12/29/14
P/E TM
--
Dividend
100.00
Dividend Yield
0.26%
Current Stock Chart for CKD BIO CORP (063160)

Related News

No related news articles were found.

ckd bio corp (063160) Related Businessweek News

No Related Businessweek News Found

ckd bio corp (063160) Details

Ckd Bio Corporation manufactures, distributes, and imports and exports pharmaceuticals. Its offers products including Cephalosporins, penicillins, rifamycins, cyclosporine, demeclocycline hydrochloride, statins, clavulanate potassium and others. The company’s finished products include systemic anti-infectives, cardiovascular system, musculo-skeletal system, alimentary tract and metabolism, antineplastics and immunologicals, respiratory system, central nervous system, parasitology, blood and blood forming organs, systemic hormons, sensory organs, and diagnostic agents. Ckd Bio Corporation was founded in 1941 and is based in Seoul, South Korea.

Founded in 1941

ckd bio corp (063160) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ckd bio corp (063160) Key Developments

Ckd Bio Corporation, Annual General Meeting, Mar 20, 2015

Ckd Bio Corporation, Annual General Meeting, Mar 20, 2015., at 09:00 Korea Standard Time. Location: Anshan plant (in Ansan identity Danwon 292). Agenda: To consider the audit reports, sales reports, external audit reports; to consider the financial statements - statement of retained earnings; to consider the election of director; to consider the appointment of audit; to consider the approval of directors' remuneration ceiling; and to consider the approval of the audit fee ceiling.

Ckd Bio Corporation, Annual General Meeting, Mar 21, 2014

Ckd Bio Corporation, Annual General Meeting, Mar 21, 2014., at 09:00 Korea Standard Time. Location: Gyeonggi-identity as Danwon 292. Agenda: To consider the audit reports, sales reports, external audit reports; to consider the financial statements - statement of retained earnings; to consider the cash dividend; to consider the election of director; to consider the appointment of audit; to consider the approval of directors' remuneration ceiling; to consider the approval of the audit fee ceiling; and to consider the incorporation of some changes.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
063160:KS 38,350.00 KRW 0.00

063160 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 063160.
View Industry Companies
 

Industry Analysis

063160

Industry Average

Valuation 063160 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book 1.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CKD BIO CORP, please visit www.ckdbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.